Abstract. It is well-known that oxidative stress and inflammatory processes are linked to the incidence of atrial fibrillation (AF). In order to provide prognostic biomarkers for AF based on lipoprotein levels, we compared the lipid and protein parameters of oxidation and inflammation in individual lipoproteins from middle-aged females with AF. We analyzed plasma and lipoproteins (VLDL, LDL, HDL 2 , HDL 3 ) from 11 female patients (mean age, 56±15 years) with paroxysmal lone AF and from a reference group of 10 female patients of similar age (mean age, 54±15 years). The AF group had normal levels of serum lipids and an inflammatory profile, except for a 7.5-and 6-fold elevation in hsCRP and tropoinin I levels, respectively. No significant differences existed in serum lipids, glucose, uric acid, creatinine and blood urea nitrogen levels between the AF and control groups. The lipoprotein particles from the AF group were more oxidized and glycated with higher triacylglycerol content compared to the control group and the particle size was smaller. The lipoprotein particles from the AF group promoted more foam cell formation via accelerated phagocytosis by macrophages compared to the control group. HDL 2 and HDL 3 from the AF group showed decreased antioxidant ability and an approximately 30% lower expression of apoA-I compared to the control group. All of these modified properties of lipoproteins, including oxidation and glycation, might be linked to the lower antioxidant ability and elevated inflammatory parameters in women with AF.
Introduction
Atrial fibrillation (AF) is the most common arrhythmia in adults. An increased prevalence of AF is anticipated with the increase in the aging population and survivability of patients with chronic heart disease (1). A growing body of evidence implicates oxidative stress in the pathogenesis and perpetuation of AF (2-4). These findings were primarily derived from studies of animal and human samples with persistent or permanent forms of AF. In addition, it is still unclear if the abnormalities observed in these studies are the basis for the arrhythmia or are a consequence of the arrhythmia itself, particularly with respect to paroxysmal lone AF.
Oxidative modification of lipoproteins is regarded as a key step in the formation of atherosclerosis (5). In addition, lipid peroxidation induces cell damage in cardiac myocytes and electrophysiologic alterations, including generation of after-depolarizations and modification of transmembrane ion currents (6) (7) (8) . Thus, it has been postulated that decreased antioxidative function, which might be present in paroxysmal AF and a consequence of increased lipid peroxidation, would provide the AF predisposing substrate. Furthermore, rapid atrial pacing or atrial tachyarrhythmias contribute to the increased expression of oxidative stress markers and electrophysiologic changes in the atria (4, 9) . In this study, we evaluated the composition and function of lipoproteins with respect to oxidation and inflammation in patients with paroxysmal lone AF, remote in time from arrhythmias to exclude the remodeling effects of the arrhythmia itself.
Dyslipidemia is an important risk factor for cardiovascular disease (CVD) and low-density lipoprotein-cholesterol (LDL-C) is a strong biomarker predictive of the risk of CVD (10). Patients with diabetes and metabolic syndrome have a strong association with atherogenic dyslipidemia, which includes high triacylglycerides (TG) and elevated small dense LDL (11). However, the patients with AF in this study and other studies (12) have a lipid profile in the normal range based on NCEP ATP III guidelines (13), indicating that a
Female patients with atrial fibrillation have increased oxidized and glycated lipoprotein properties and lower apolipoprotein A-I expression in HDL
SEONG-MIN KIM 1* , JI-HyE LEE 1* , JAE-RyONG KIM 2 , DONG-Gu SHIN 3,4 , SANG-HEE LEE 3 and KyuNG-HyuN CHO different pathological mechanism might be involved in the development of AF. To overcome this discrepancy between the serum lipid profile and the pathophysiology of AF, the composition and function of lipoproteins should be investigated. The antioxidant ability of serum is highly dependent on the extent of LDL oxidation and the capability of HDL to exert anti-inflammatory activity (14). HDL exerts many beneficial effects for the maintenance of a healthy physiological system, including antioxidant, anti-inflammatory and anti-thrombotic effects (15, 16) . These activities are exerted in accordance with the composition of essential apolipoproteins and associated enzymes.
This study was designed to compare individual lipoprotein properties between female patients with AF and gender-and age-matched controls to provide distinct biomarkers in apolipoprotein and lipoprotein metabolism. To identify unique properties in lipoprotein levels regarding oxidation and inflammation, we isolated lipoproteins from middle-aged females with AF by sequential ultracentrifugation.
Materials and methods
Patients. This study was comprised of 11 female patients (mean age, 56±15 years) with paroxysmal lone AF and a reference group of 10 female patients of similar age (mean age, 54±15 years). The reference patients had structurally normal hearts and were undergoing radiofrequency ablation for atrioventricular nodal reentrant tachycardia with no history of AF. Paroxysmal AF was defined according to the Executive Summary on Practice Guidelines as recurrent AF that terminates spontaneously within 7 days (17). Patients were excluded from the study group if they had AF during the week before enrollment (confirmed by continuous monitoring) and if they had a medical history or clinical evidence of systemic diseases, such as hypertension, hyperthyroidism, and diabetes. The absence of structural heart disease or coronary artery disease (CAD) was confirmed based on history, physical examination, chest X-ray, routine blood chemistry, exercise stress test, and transthoracic and transesophageal echocardiography, if needed. All anti-arrhythmic medications or statins for the treatment of dyslipidemia were not used before the study. All patients provided written informed consent. The study protocol was approved by the Institutional Review Board at the yeungnam university Medical Center in Daegu, Republic of Korea.
Echocardiography. Two-dimension and Doppler echocardiographies were performed by one experienced sonographer using a GE Vivid 4 System (GPS Medical, Indianapolis, IN, uSA) at the time of sampling. Left ventricular end-diastolic diameter and left atrial (LA) dimension were measured by M-mode-derived anteroposterior linear dimension from the parasternal long axis view as recommended by the American Society of Echocardiography. The left ventricular ejection fraction (LVEF) was calculated using a modified Simpson rule.
Plasma analysis. Blood was obtained following an overnight fast from AF patients and controls. Blood was collected using a vacutainer (BD Biosciences, Franklin Lakes, NJ, uSA) containing EDTA (final concentration, 1 mM). Plasma was isolated by low-speed centrifugation and stored at -80˚C until analysis. Blood parameters, lipids, and glucose concentrations were determined using an automatic blood analyzer (Chemistry Analyzer Au4500; Olympus, Tokyo, Japan).
Isolation and characterization of lipoproteins. Very low-density lipoproteins (VLDL, d<1.019 g/ml), LDL (1.019<d<1.063), HDL 2 (1.063<d<1.125), and HDL 3 (1.125<d<1.225) were isolated from individual patient and control sera via sequential ultracentrifugation (18), with the density adjusted by the addition of Nacl and NaBr in accordance with standard protocols. Samples were centrifuged at 100,000 x g for 24 h at 10˚C using a Himac CP-90α (Hitachi, Tokyo, Japan).
For each of the lipoproteins which were individually purified, total cholesterol (TC) and triglycerides (TG) measurements were obtained using commercially available kits (T-CHO and Cleantech TS-S; Wako Pure Chemical, Osaka, Japan). The protein concentrations of lipoproteins were determined via the Lowry protein assay, as modified by Markwell et al (19) using the Bradford assay reagent (Bio-Rad, Seoul, South Korea) with bovine serum albumin (BSA) as a standard. To assess the degree of oxidation of individual LDL, the concentration of oxidized species in LDL (oxLDL) was determined by the thiobarbituric acid reactive substances (TBARS) method using malondialdehyde (MDA) as a standard (20).
To compare the extent of glycation between the groups, the content of advanced glycation end products (AGEs) in the individual lipoproteins were determined from reading the fluorometric intensities at 370 nm (excitation) and 440 nm (emission), as described recently by our research group (21).
Copper-mediated LDL-oxidation.
To compare the susceptibility of copper-mediated LDL oxidation, 300 µg of LDL were incubated with 5 µM CuSO 4 for up to 3 h. During the incubation, the quantity of formed conjugated dienes was monitored by measuring the absorbance at 234 nm (Abs 234 ) at 37˚C (22) using a Beckman Du800 spectrophotometer (Beckman Coulter, Fullerton, CA, uSA) equipped with a MultiTemp III thermocirculator (Amersham, uppsala, Sweden) .
In order to verify the spectroscopic data, the oxLdL samples were subjected to electrophoresis on a 0.5% agarose gel for an electromobility comparison (23). The post-oxidative electrophoretic mobility of LDL was compared via electrophoresis on a 0.5% agarose gel because there is some modification of amino acids in apo-B by oxidation.
Ferric-reducing ability of plasma assay. The ferric-reducing ability of plasma (FRAP) was determined using the method described by Benzie and Strain (24) with a slight modification, as described recently by our research group (25).
Briefly, the FRA reagents were freshly prepared by mixing 25 ml of 0.2 M acetate buffer (pH 3.6), 2.5 ml of 10 mM 2,4,6, tripyridyl-s-triazine (TPTZ; Fluka Chemicals), and 2.5 ml of 20 mM FeCl 3 •6H 2 O. The antioxidant activities of HDL 3 were then estimated by measuring the increase in absorbance induced by the generated ferrous ions. The freshly prepared FRA reagent (300 µl) was mixed with equally diluted HDL 3 (2 mg/ml, 10 µl), which was dialyzed extensively against PBS, after which the FRA was determined by measuring the absorbance at 593 nm every 20 sec over a 10-min period at 25˚C using a Du800 spectrophotometer equipped with a MultiTemp III thermocirculator.
Cholesteryl ester transfer assay. A reconstituted HDL (rHDL)-containing apoA-I and cholesteryl oleate was synthesized in accordance with the method described by Cho et al (26) using trace amounts of [ 3 H]-cholesteryl oleate (TRK886, 3.5 µCi/mg of apoA-I; GE Healthcare) as a CE-donor. Next, to facilitate separation from the CE-acceptor, the rHDL was immobilized using a CNBr-activated Sepharose 4B resin (Amersham Biosciences), according to the manufacturer's instructions.
The CE-transfer reaction was allowed in 300 µl reaction mixtures that contained each of the serum samples (20 µl) as a cholesteryl ester transfer protein (CETP) source, rHDL-agarose (50 µl, 0.25 mg/ml), and human LDL (50 µl, 0.25 mg/ml) as a cholesteryl (cE)-donor and -acceptor, respectively. After incubation for 6 h at 37˚C, the reaction was halted via brief centrifugation (10,000 x g) for 3 min at 4˚C. The supernatant, which contained the CE-acceptor (150 µl), was then subjected to scintillation counting, and the percentage transfer of [ 3 H]-CE from rHDL to LDL was calculated.
Paraoxonase assay. Paraoxonase-1 (PON-1) activity toward paraoxon was determined by evaluating the hydrolysis of paraoxon into p-nitrophenol and diethylphosphate, which was catalyzed by the enzyme (27). PON-1 activity was then determined by measuring the initial velocity of p-nitrophenol production at 37˚C by measuring the absorbance at 405 nm (microplate reader, Bio-Rad model 680; Bio-Rad, Hercules, cA, USA).
Western blot analysis. The apolipoprotein/lipoprotein compositions were compared via sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) with identical protein loading quantities from individual HDL 2 (3 µg total protein per lane) and HDL 3 (5 µg total protein per lane), and the level of expression of apolipoprotein was analyzed via immunodetection. Goat anti-human apoA-I antibody (ab7613) was purchased from Abcam (Cambridge, uK) as a primary antibody. Anti-goat immunoglobulin G (SC2020; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, uSA) was used as the secondary antibody. The relative band intensity (BI) was compared via band scanning with Gel Doc ® XR (Bio-Rad) using Quantity One software (version 4.5.2).
Transmission electron microscopy (TEM)
. TEM was performed with a Hitachi electron microscope (model H-7600; Ibaraki, Japan) operating at 80 kV, as in our previous report (28). VLDL, LDL, and HDL were negatively stained with 1% sodium phosphotungstate (PTA; pH 7.4) with a final apolipoprotein concentration of 0.3 mg/ml in TBS. Each lipoprotein, 5 µl of a 0.3 mg/ml suspension, was blotted with filter paper and immediately replaced with a 5 µl droplet of 1% PTA. After a few seconds, the stained lipoprotein fraction was blotted onto a Formvar carbon-coated 300 mesh copper grid and air-dried. The shape and size of lipoproteins were determined by TEM photography at a magnification of x40,000.
Data analysis. All data are expressed as the mean ± SD from at least three independent experiments with duplicate samples. Data comparisons were assessed by the Student's t-test using the SPSS program (version 14.0; SPSS, Inc., Chicago, IL, USA).
Results
Baseline characteristics. Although the AF group had a slightly higher BMI than the control group, there was no difference in the BMI and systemic blood pressure between the groups, and the BMIs and systemic blood pressures were in the normal range, as shown in Table I . No significant difference in the LVEF and LA dimension between the groups was detected, although the LA size was slightly larger in the AF group. The plasma levels of TC, TG, HDL-C, and LDL-C of the AF group were similar to the control group. There was no difference in the plasma CETP activity between the AF and control groups (Table I) . Additionally, there were no differences in glucose, uric acid, creatinine, and blood urea nitrogen levels between the groups, indicating that carbohydrate metabolism and kidney function were normal. Although other inflammatory parameters (GOT and GPT) were at similar level between the groups, the AF group had a 7.5-and 6-fold 
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higher of hsCRP and troponin I, respectively, than the control group, suggesting the possibility that the AF group may have had myofibril damage with inflammation.
Lipoprotein properties. In patients with AF, VLDL and LDL were well-developed and enriched with cholesterol and TG, as shown in Table II . Especially with respect to LDL, the AF group had 25% more enriched TG content than the control. HDL 2 from patients with AF had a 4.3-fold increased TG content compared to controls. Based on the lipid/protein ratio, LDL and HDL 2 from the AF group had a 1.5-and 1.7-fold increased TG/TP ratio, respectively, compared to the control group. However, there was no significant difference in the TC and TG content in HDL 3 between the groups.
AF-LDL was more sensitive to oxidation. Monitoring of the conjugated diene level revealed that the AF group had a t 1/2 max of 27 min, while the control group had a t 1/2 max of 44 min, as shown in Fig. 1A , suggesting that the LDL in patients with AF was 1.6-fold more sensitive to oxidation. Agarose electrophoresis revealed that the LDL samples from all of the patients with AF migrated to the bottom with darker intensity, while some of the LDL from the controls remained in the native state (as indicated by the arrow in Fig. 1B) . These results indicate that cupric ion-mediated LDL oxidation was more sensitive in the AF group. However, there was no difference in the oxidation sensitivity of HDL 2 and HDL 3 between the groups (Fig. 1) . uV quantification (234 nm) revealed that all lipoprotein fractions from the AF group contained more conjugated diene species, except HDL 2 , based on an equal amount of protein, as shown in Fig. 1C . Quantification of the oxidized species by TBARS using an MDA standard showed that AF-VLDL and AF-LDL contained a much higher content of MDA; AF-VLDL and AF-LDL were 2-and 3.3-fold higher than the control group, respectively (Fig. 1D) .
Antioxidant potential. Plasma FRA ability and PON activity were decreased by 12% and 24% decreased, respectively, in the AF group compared to controls, as shown in Fig. 2A . Based on the same protein concentrations in the HDL 2 and HDL 3 fractions, the AF group had weaker ferric ion removal ability than the control group, as shown in Fig. 2B .
More glycated species in lipoproteins from the AF group.
Fluorescence measurement revealed that all lipoprotein fractions from the AF group had a higher content of AGEs, as shown in Fig. 3 . Specifically, VLDL and LDL from the AF group had a greater extent of glycation based on an equal amount of protein (20% and 54% more content of AGE species than the control group, respectively).
Lower level of apoA-I in AF-HDL 2 . As shown in Fig. 4A , electrophoretic analysis of HDL 2 and HDL 3 revealed similar patterns of expression of apolipoproteins, except that the level of expression of apoA-I was much lower in the HDL 2 fraction from patients with AF. Western blot analysis revealed that the average band intensities of apoA-I were 0.9±0.2 and 1.3±0.1 for the HDL 2 fractions from patients with AF and controls, respectively (p=0.002); the level of expression of apoA-I was approximately 30% lower in the AF group than in controls. However, the level of immuno-detected apoA-I in the HDL 3 fraction was similar between the groups; specifically, the average of the band 
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intensity (BI, indicated as the lower number) was approximately 1.6-1.7 for both groups, as shown in Fig. 4B .
Particle size of lipoproteins. Electron microscopy revealed that the AF group had a significantly smaller particle size of lipoproteins, as shown in Fig. 5 . The LDL fraction from the patients with AF were 20 and 23 nm for width and length (W x L), while the LDL fraction from controls were 24 and 25 nm for W x L (data not shown). The HDL 2 (0.3 mg/ml) and HDL 3 fractions (0.5 mg/ml) from the AF group were 26-33% smaller than the controls in W x L. The size of the HDL 2 fraction from the females with AF and controls using Western blotting analysis with apoA-I antibody, which was raised by full-length apoA-I (ab7613; Abcam). The numbers below the blots indicate the relative band intensity (BI), which was analyzed using Gel Doc ® XR (Bio-Rad).
Figure 5. Representative photo of negatively-stained LDL, HDL 2 , and HDL 3 from patients with AF and controls (electron microscopy). All micrographs are shown at a x40,000 magnification. The scale bar corresponds to 100 nm. The table shows the dimensions and area of each HDL. ** p<0.01 vs. control; *** p<0.005 vs. control.
computer-assisted morphometry was 205±105 nm 2 and 283±96 nm 2 , respectively; the size of the HDL 3 fraction from patients with AF and controls was 60±13 and 86±21 nm 2 , respectively. Thus, the size of the HDL 2 and HDL 3 fractions were reduced 28% and 31%, respectively, which is in good agreement with the measurement of W x L.
Acceleration of lipoprotein phagocytosis into macrophages.
After a 48-h incubation, addition of VLDL (7.5 µg of protein) or LDL from patients with AF (16.5 µg of protein) into the cell medium resulted in a much stronger red intensity than the same amount of VLDL and LDL from controls, while PBS-treated cells did not exhibit red intensity, as shown in Fig. 6 . This result indicates that VLDL and LDL from the AF group could be more easily taken up into macrophages by phagocytosis. Determination of the oxidized species within the culture media treated with the VLDL and LDL from patients with AF contained 4.7 nM and 3.8 nM of MdA, respectively, while media treated with VLDL and LDL from controls contained 2.3 and 2.5 nM of MDA, respectively, as shown in Fig. 6 . These results suggest that LDL from patients with AF, which was more oxidized and glycated, accelerated the production of foam cells.
Discussion
Oxidative stress and inflammation have been linked to the pathogenesis and perpetuation of AF (2-4). Gene expression profiling on heart tissues from patients with AF suggest that oxidative stress-related genes are up-regulated. However, these findings are derived mostly from studies of chronic AF patients. The role of oxidative stress in paroxysmal lone AF is still unclear, and there have been no reports to compare the extent of oxidation and inflammation at the lipoprotein level. To identify this factor, we studied patients with paroxysmal lone AF who were remote from an episode of AF, thereby removing the effects of acute rate-related remodeling.
In the present study, we found that patients with paroxysmal lone AF had more oxidized (Fig. 1) and glycated ( Fig. 3) lipoproteins with decreased plasma antioxidant ability (Fig. 2) and less apoA-I in HDL 2 (Fig. 4) . In addition, the AF group had smaller lipoprotein particle size (Fig. 5) and increased TG content (Table I ) with accelerated foam cell formation (Fig. 6) . Thus, we posit that these changes in lipoprotein profile and decreased antioxidant ability which occur in lone paroxysmal AF remotely from arrhythmia represent one of the essential contributors to the development of the initial substrate and progression of AF. The progression and perpetuation of AF may cause a vicious cycle which further makes the atrial substrate worse and susceptible to AF.
The occult abnormalities described in previous studies of paroxysmal lone AF were abnormal atrial histology, including patchy fibrosis (29), inflammation (30), and microvascular dysfunction in the coronary circulation (31). Stiles et al (32) stated that all of these features contributed to their observations of an abnormal substrate, the so-called 'second factor' in lone AF. We assume that these abnormalities, which we noted in the present study, may precede the occurrence of an abnormal substrate as a second factor as Stiles et al have reported (32) .
unlike in other cardiovascular diseases, AF patients did not show notable dyslipidemia in the current or in another study (12) . Patients with paroxysmal lone AF have similar blood pressures serum cholesterol, HDL-C, LDL-C, TG, and fasting glucose levels; however, inflammatory parameters are increased in AF patients (33). Similarly, Zhang et al (34) reported that vascular cell adhesion molecule (VCAM)-1, hsCRP, and urotensin-II levels were significantly elevated in patients with paroxysmal lone AF. A Framingham offspring cohort study revealed that CRP and fibrinogen are elevated in the AF group (35). The cumulative evidence suggests that oxidative stress in myofibrils is directly associated with the incidence of AF (36). In this report, we showed that the AF Figure 6 . Cellular uptake of VLDL and LDL into macrophages. PMA differentiated THP-1 cells were incubated with 50 µl of VLDL (0.15 mg/ml) or LDL (0.33 mg/ml) from the AF or control groups in the presence of 450 µl of RPMI-1640 media. The extent of cellular uptake of the lipoproteins by macrophages was then compared by oil red O staining, as described in the text. The cells were then photographed using a Nikon Eclipse TE2000 microscope (Tokyo, Japan) at x400 magnification.
group exhibited more oxidized VLDL and LDL with acceleration of foam cell production than the control group.
The oxidative modification of LDL, which is considered to be a strong risk factor for atherosclerosis and ACS, occurs through the release of pro-inflammatory and oxidative signals. The AF group also showed less PON activity and antioxidant potential in the HDL fraction (Fig. 2) . Reduced PON activity is associated with a higher prevalence of CAD and arrhythmias in patients with myocardial infarction and ST-elevation (37). In general, the PON1 enzyme is physically associated with the HDL 3 fraction and most of the PON activity exists in the HDL 3 fraction, as well as other antioxidant enzymes (38). PON1 attenuates the oxidation of LDL via inhibition of the accumulation of lipid peroxides in LDL (39). The LDLs from the AF group were more easily oxidized by cupric ion treatment and had a higher content of oxidative stress ( Fig. 1 and 2) . Although more evidence is required to make concrete conclusions, the current results suggest that more highly oxidized lipoproteins might be a reason for AF rather than a result of AF.
Because there have been no reports to compare the extent of oxidation and inflammation in the lipoprotein level, we characterized the lipoprotein properties in female patients with AF in the current study. AF patients had more oxidized and glycated VLDL and LDL and an increased level of TG content (Table II) in LDL and HDL 2 , although the blood level of TG was in the normal range (Table I) . It has been well-established that the serum TG level is an independent risk factor for CAD (40) and metabolic syndrome (41). The current study and other studies have suggested that TG-rich lipoproteins are pro-atherogenic and more specific to myocardial infarction (25), as well as to metabolic syndrome (42). The presence of increased TG in lipoproteins is in good agreement with the results of previous studies that indicated that TG levels are an important and independent predictor of CAD and stroke risk in the Asia-Pacific region (43). Furthermore, VLDL and LDL from the AF group, which were more oxidized and glycated, and had a smaller particle size, exhibited increased facilitated phagocytosis into macrophages with increased production of oxidized species (Fig. 6) . These results are in good agreement with previous reports that TG-rich lipoproteins are pro-atherogenic (44) and TG-enriched VLDL are toxic to endothelial cells (45).
The apolipoproteins, apoA-I and apo-B, are the primary protein constituents of HDL and LDL, respectively. In the healthy state, HDL exerts many beneficial effects for the maintenance of a healthy physiological system, including antioxidant, anti-inflammatory, and anti-thrombotic effects (15). The AF patients in this study showed significantly lowered apoA-I levels in the HDL 2 fraction (Fig. 4) , indicating a reduced antioxidant potential. LDL is the major cholesterol carrier in the plasma with a heterogeneous particle size and composition. Small dense LDL, which is easily oxidized and glycated via interaction with reactive oxygen species and carbohydrate in the blood, are increased with progression of aging, diabetes mellitus, and CAD (46). The patients with AF in this study had smaller LDL and HDL particle sizes (Fig. 5) , and AF-LDL was more easily taken up by macrophages (Fig. 6) . Furthermore, the VLDL and LDL from patients with AF were more highly glycated (Fig. 3) . These modifications of LDL particle size and extent of glycation are in good agreement with a previous report that small dense LDL is more preferentially glycated (47). In addition, more highly glycated LDL increases CC chemokine receptor-2 expression in macrophages and monocyte chemoattractant protein-1 mediated chemotaxis (48). Moreover, our research group recently reported an elevated level of LDL glycation in an elderly group (mean age, 71±4 years), which had a higher inflammatory profile with a loss of antioxidant ability (49).
In conclusion, we have shown that the lipoprotein properties of AF patients are more oxidized and modified with a smaller particle size compared to controls. VLDL and LDL promoted more foam cell formation via accelerated phagocytosis of macrophages. HDL 2 from the AF group had a lower apoA-I content and smaller particle size with decreased antioxidant ability. All of these modified properties, including oxidation and glycation of lipoproteins, might be connected to lowered antioxidant ability and elevated inflammatory parameters in the blood of patients with AF.
